Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Lobe Sciences Ltd. C.LOBE

Alternate Symbol(s):  LOBEF

Healthcare Drug Manufacturers - Major
Lobe Sciences is a leading “BioPsychedelic” company entering clinical stage development focused on transforming psychedelic medicine to benefit patients of all ages. We are engaged in research and development using psychedelic and non-psychedelic compounds targeting the 5HT2 receptor family. Our team is made up of biotech executives who collectively have managed the development and regulatory... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:LOBE)

Lobe Sciences Provides Company Review of 2023

Business Wire January 8, 2024

Lobe Sciences Provides Update on L-130 Clinical Program

Business Wire December 7, 2023

Lobe Sciences Provides Update on L-130 Oral Psilocin Compound

Business Wire December 5, 2023

Lobe Sciences, Ltd. Announces The Appointment Of Mathew Lee As CFO

Business Wire September 18, 2023

Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia(TM) & Company

Business Wire September 14, 2023

Lobe Sciences Announces Additional Details Regarding the Acquisition of Altemia(TM) & Company

Newsfile June 30, 2023

Lobe Sciences Initiates Phase 1 Clinical Trial of L-130

Business Wire June 27, 2023

Lobe Sciences Appoints Baxter Phillips III, MBA as Chief Operating Officer

Business Wire June 7, 2023

Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia(TM)

Business Wire May 17, 2023
View More News ››

Opinion & Analysis (CSE:LOBE)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:LOBE)

Looks like $LOBE has been busy in 2023

Year end financials are out and it looks like 2024 might be the year the stock runs thanks to Altemia, which is the company's first...
AgileTrader - February 15, 2024

Lobe Sciences Announces Commercial Distribution Agreement

May 17, 2023 08:45 AM Eastern Daylight Time VANCOUVER, British Columbia--(BUSINESS WIRE)--Lobe Sciences Ltd. (CSE: LOBE...
Betteryear2 - May 17, 2023
View more Bullboard ››

Slam Exploration Ltd

Slam Exploration Ltd

SLAM Exploration Ltd. is a Canadian junior resource company holding a portfolio of gold and base metal projects. The Company ...
View More »